Artificial Vital Organ And Medical Bionics Product Outlook By 2022

The global Artificial Vital Organs And Medical Bionics Market is expected to reach USD 45.92 billion by 2022, according to a new report by Grand View Research Inc. Key growth drivers identified in the artificial vital organs market include increasing base of geriatric population suffering from chronic diseases such as cardiovascular and respiratory diseases leading to organ failures or damage.

artificial-vital-organs-and-medical-bionics-market

Furthermore, the increasing number of patients suffering from physical disabilities such as loss of limbs and arms owing to congenital factors, accidents, serving in armed forces and industrial accidents is likely to positively reinforce medical bionics market growth over the forecast period.

The proliferation of universal health coverage schemes launched by various governments and increasing public and private reimbursement policy coverage are major trends expected to boost the usage rates of artificial vital organs and medical bionics in the next seven years.

The artificial vital organs market includes products such as artificial heart, pancreas, kidneys, and lungs. These are used for organ transplantation in patients suffering with organ damages or complete organ failures.

In 2014, artificial kidney market accounted for the largest market share of over 60% owing to increasing prevalence of high blood sugar, hypertension, post-surgery infections, glomerular diseases, injury or burns, HIV, and other risk factors.

Artificial liver is expected to be the fastest growing product segment growing at a lucrative rate over the forecast period of seven years. Key factors attributing to its rapid growth include increasing prevalence of chronic lung diseases such as COPD and disadvantages of using mechanical ventilators.

The medical bionics segment includes products such as brain, ear, vision bionics, exoskeleton, and bionic limbs. In 2014, brain bionics held the largest market share of nearly 41% due to the continually increasing number of patients suffering from neurological conditions. Furthermore, non-invasive nature of spinal cord stimulators, vagus nerve stimulators, and deep brain stimulators are key factors positively impacting market growth in the next seven years. Exoskeletons are likely to witness a rapid rise in demand owing to its wide applications in rescue, emergency response, home healthcare, and patient rehabilitation.

Browse Full Research Report on Artificial Vital Organs And Medical Bionics Market: http://www.grandviewresearch.com/industry-analysis/artificial-vital-organs-and-medical-bionics-market

Further key findings from the report suggest:

  • North America accounted for the largest market share of over 40% in 2014 owing to increasing prevalence of geriatric population suffering with organ damages or failures coupled with increasing numbers of physically challenged persons opting to use prosthetic limbs due to rising awareness and better reimbursement policies for such procedures
  • Asia Pacific is expected to be the fastest growing market in the next seven-year period. Key factors contributing to growth in Asia Pacific are increase in public and private healthcare expenditure, penetration of healthcare insurance across urban and rural centers. Furthermore, increase in chronic diseases and increase in medical tourism are also expected to significantly boost the artificial vital organ transplant and medical bionics market over the forecast period.
  • The global vital organ transplant and medical bionics market is dominated by players such as Abiomed, Touch Bionics, Baxter, Medtronics, Ottobock Healthcare, and Heartware.

Grand View Research has segmented the global artificial vital organs and medical bionics market on the basis of product type and region.

Artificial Vital Organ And Medical Bionics Product Outlook (Market Revenue in USD Million, 2012 – 2022)

  • Artificial vital organs
    • Artificial heart
    • Artificial kidney
    • Artificial liver
    • Artificial pancreas
    • Artificial lungs
      • Oxygenators
      • Heart-Lung bypass machines
    • Medical bionics
      • Ear bionics (cochlear implants)
      • Vision bionics
      • Exoskeletons
      • Bionic limbs
        • Bionic leg
        • Bionic hand
      • Brain bionics
        • Spinal cord stimulators
        • Deep brain stimulators
        • Vagus nerve stimulators
      • Cardiac bionics
        • Ventricular Assist Device (VAD)
          • Left Ventricular Assist Device (LVAD)
          • Right Ventricular Assist Device (RVAD)
        • Heart valves
          • Mechanical heart valves
          • Biological tissue valves
          • Transcatheter heart valves

Artificial Vital Organ And Medical Bionics Regional Outlook (Market Revenue in USD Million, 2012 – 2022)

  • North America
  • Europe
  • Asia Pacific
  • ROW

Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-artificial-vital-organs-medical-bionics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Advertisements

Untapped Profitable business opportunities and Emerging Trends in Cancer Sub Sector of Healthcare Industry will have positive impact on Genomics Market Growth

Global Genomics In Cancer Care Market is expected to reach USD 9.22 billion by 2022, according to a new report by Grand View Research, Inc. Increasing prevalence of cancer coupled with adoption of next generation sequencing for the diagnosis & treatment is expected to fuel the market with future growth opportunities. Increasing incidences of cancer triggers the demand for cost effective and accurate diagnostics in coming years.

genomics-in-cancer-care-market.png

In addition, increasing demand for personalized medicines in molecular characterization of cancer to identify therapeutic targets is the factor attributing towards the market growth. Similarly, factors such as cost reduction in genome sequencing, growing healthcare expenditure levels and development of effective diagnostics & therapeutic procedures for cancer are responsible for the potential growth of genomics in cancer care.

Browse Full Research Report on Genomics In Cancer Care Market: http://www.grandviewresearch.com/industry-analysis/genomics-in-cancer-care-market

Further key findings from the study suggest:

  • Instrument segment dominated the overall market in terms of revenue share as of 2014 and accounted for 33.4% of market owing to high cost associated with it. Whereas, consumables are most widely used product segment in genome testing as they are indispensible component and frequently required to perform the test.
  • Demand for services such as next generation sequencing, PCR and other such as cancer risk management & genetic testing are expected to grow over the forecast period due to increasing outsourcing activities to perform genome analysis. High cost of performing genetic tests and growing awareness pertaining to associated benefits with the use of these technologies are high impact rendering drivers for this segment.
  • Drug discovery and development segment is expected to show lucrative CAGR of 17.6% during the forecast period owing to increasing demand for effective treatment for cancer and growing investment in biomedicines by manufacturers for the development of novel products.
  • Genome sequencing held the dominant share of technology segment as it is most prominently used for diagnosis due to associate benefits such as faster and accurate method. It is expected to show significant growth rate of 17.5% in coming years owing to remarkable decrease in the cost for genome sequencing and increasing adoption rates.
  • The cancer research segment held the largest share of 34.1% in 2014 due to increasing demand for faster & accurate diagnostic methods to treat variety of cancer. Other use such as commercial adoption of genetic testing is expected to be fastest growing segment owing to increasing demand of cancer genomic testing to fulfill unmet needs in healthcare sector.
  • Some key players operating in this market include Beckman Coulter Inc., Illumina, Inc, Affymetrix, Roche Diagnostics, Agilent Technologies, Cancer Genetics Inc., Danaher Corporation, Bio-Rad Labs, Pacific Biosciences, Quest Diagnostics, Sigma Aldrich, Luminex, Thermo Fisher scientific, Oxford Gene Technology., PerkinElmer, Qiagen, and GE Healthcare.

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

Grand View Research has segmented the global genomics in cancer care market on the basis of application and region: 

Global genomics in cancer care product outlook (Revenue, USD Million, 2012 – 2022)

  • Instruments
  • Consumables
  • Services

Global genomics in cancer care application (Revenue, USD Million, 2012 – 2022)

  • Diagnostics
  • Personalized medicine
  • Drug discovery & development
  • Research

Global Genomics in cancer care technology  Outlook (Revenue, USD Million, 2012 – 2022)

  • Genome sequencing
  • PCR
  • Microarrays
  • Nucleic acid extraction & purification
  • Other

Genomics in cancer care regional outlook (Revenue, USD Million, 2012 – 2022)

  • North America
    • U.S
    • Canada
  • Europe
    • U.K
    • Germany
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Mexico
    • Brazil
  • MEA
    •  South Africa

Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-genomics-in-cancer-care-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Growing demand for Organ Transplantation & Tissue Engineering for Treatment of chronic diseases is likely to pushing 3D Cell Culture Market toward rapid growth

The global 3D Cell Culture Market is anticipated to reach USD 1.69 billion by 2024, according to a new report by Grand View Research, Inc. Potential of this technology to replace and reduce the usage of animal models for histological analysis and biochemical assays is expected to fuel demand for 3D cell culture products thus driving growth in the coming years.

3d-cell-culture-market.png

Advent of technology with respect to spheroid formation and matured assay methods, is expected to boost the emergence of 3D optimized assays, kits, and protocols, in turn, expediting the entire research process. In addition, the scope of three-dimensional (3D) cell culturing experiments for evaluation of drug moiety is anticipated to grow owing to advantages associated with its usage. These advantages include increased cell to extra cellular matrix (ECM) as well as intercellular interactions, variation in the proliferation zones, ease for analyzing impact of site-specific stromal tissue components in the tumor microenvironment.

Research initiatives carried out to develop multidimensional cultures that offer compatibility with automated lab equipment and suitability for HTS feature in order to facilitate high content screening assay, signaling, and migration are expected to fuel the growth of this vertical through to 2024.

Browse Full Research Report on 3D Cell Culture Market: http://www.grandviewresearch.com/industry-analysis/3d-cell-culture-market

Further key findings from the report suggest:

  • Scaffold-based technique accounted for the revenue share of over 40% because of the potential these possess for the recreation of structural and physical environment of a living tissue. Availability of choice for the material and structure of the scaffold for different in vitro applications is supportive for the estimated revenue share of this segment. Hydrogel or ECM and solid scaffolds are estimated to capture a comparatively sizable share of the revenue, attributed to the presence of different products in this segment.
  • Spheroid development techniques are estimated to contribute significantly in increasing the revenue share of scaffold-free technology. These enable multicellular arrangement, thus making them an influential tool for a range of applications, particularly in cancer and stem cell research.Oncology is estimated to account for the dominant share in 2015 owing to the presence of higher incidence rate of cancers coupled with phenotypic heterogeneity achieved using 3D culturing. Stem cell research is anticipated to witness lucrative growth in the coming years as a consequence of the upcoming projects in this segment for development of effective therapies.
  • Key end users for this technology are pharma & biotech entities, research laboratories and institutes. Pharma & biotech entities accounted for the largest share of the revenue in 2015 owing to the high usage of technology in different steps of drug discovery which include target validation, lead optimization, penetration studies, and safety assessment or toxicity screening.
  • North America dominated the next generation sequencing data analysis market with a share of over 40% as a result of the presence of several organizations operating in this region. Moreover, the significant number of R&D projects carried out in institutes is resulting in the high demand, affecting the revenue growth significantly.
  • However, Asia Pacific is expected to witness substantially high growth through to 2024, which is attributable to the rise in number of research grants for drug development and tissue engineering projects in the developing economies of this region. Furthermore, positive R&D outcomes encouraging the incorporation of three dimensional cultures in regenerative medicine is expected to impact this sector with potential opportunities for growth.
  • The market is fragmented in nature and includes established as well as emerging players These entities include 3D Biomatrix, Corning Inc, Nano3D Biosciences, Merck, Becton Dickinson and Company, Thermo Fisher Scientific, InSphero AG, Lonza Group, Tecan, 3D Biotek LLC, VWR International, LLC, and Global Cell Solutions, Inc.
  • These companies are involved in collaborations and co-marketing agreements for enhancement of product portfolio as well as global presence. For instance, Tecan and CellSpring entered into collaboration for automation of the 3D Bloom platform on a Freedom EVO workstation.

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

Grand View Research has segmented 3D cell culture market on the basis of technology, application, end use and region:

Global 3D Cell Culture Outlook, by Technology (Revenue, USD Million, 2013 – 2024)

  • Scaffold Based
    • Hydrogels
    • Polymeric Scaffolds
    • Micro – patterned Surface Microplates
  • Scaffold Free
    • Hanging Drop Microplates
    • Spheroid Microplates with ULA coating
    • Microfluidic 3D Cell Culture
    • Magnetic Levitations & 3D Bioprinting
  • Bioreactors

Global 3D Cell Culture Outlook, by Application (Revenue, USD Million, 2013 – 2024)

  • Cancer
  • Tissue Engineering & Immunohistochemistry
  • Drug Development
  • Stem Cell Research
  • Others

Global 3D Cell Culture Outlook, by End – use, (Revenue, USD Million, 2013 – 2024)

  • Biotechnology and Pharmaceutical Industries
  • Research Laboratories and Institutes
  • Hospitals and Diagnostic Centers
  • Others

Global 3D Cell Culture Market, Regional Outlook (Revenue, USD Million, 2013 – 2024)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Brazil
  • MEA
    • South Africa

Access Press Release of this Report: http://www.grandviewresearch.com/press-release/global-3d-cell-culture-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Growing Obesity, Hypertension and sedentary lifestyle is anticipated to driving Growth to the Wearable Medical Devices Market swiftly Till 2022

The Global Wearable Medical Device Market is expected to reach USD 27.8 billion by 2022, according to a new report by Grand View Research, Inc. Rising prevalence of conditions such as obesity and hypertension, as a result of sedentary lifestyle is anticipated to boost the demand for wearable medical devices. Moreover, increasing health awareness is further expected to augment the demand for these devices.

wearable-medical-devices-market.png

Additionally, growing incidences of chronic conditions, such as diabetes, which require round-the-clock monitoring, are expected to increase the demand for wearable technology. Technological innovation is projected to be vital for growth of this industry over the forecast period. Smart watches, smart bands, and smart clothing are anticipated to be the key areas for development. Increasing penetration of smart cellular phones is expected to assist growth of this technology. However, patient privacy and security concerns along with complexity in engineering are expected to impede growth of the industry.

Browse Full Research Report on Wearable Medical Device Market http://www.grandviewresearch.com/industry-analysis/wearable-medical-devices-market

Further key findings from the study suggest:

  • Diagnostic wearable medical devices held substantial share in 2014 owing to increasing usage in remote patient monitoring as well as home healthcare
  • Therapeutic wearable devices are anticipated to exhibit remunerative growth over the forecast period. Increasing penetration of products, such as insulin monitors, is assisting the growth of wearable equipment.
  • Diagnostic devices such as vital sign monitors are expected to witness lucrative growth over the forecast period. Rising incidences of chronic diseases are expected to boost the demand for this equipment.
  • Wearable medical devices have applications in sports & fitness monitoring, home healthcare, and remote patient monitoring. Home healthcare held significant shares of around 50.0% in 2014. Simplified usage of this equipment along with ability to synchronize with cellular phones as well as tablet devices assisted the growth of this segment.
  • On the contrary, remote patient monitoring is projected to exhibit growth rate of over 25.00% in the next seven years. Increasing geriatric population base coupled with demand for continuous monitoring is expected to fuel the growth.
  • Strap/clip/bracelet or watches held substantial shares of around 40.0% in 2014, and is expected to grow at a lucrative rate over the forecast period. Simplified engineering, aesthetically appealing products, and synchronization with mobile application are anticipated to drive this segment’s growth.
  • North America dominated the overall market with approximately 40.0% of shares. This can be attributed to increasing per capita income as well as rising healthcare spending, and advanced healthcare infrastructure and presence of OEM in this region.
  • Asia Pacific is projected to grow with a rapid rate of around 32.0% over the forecast period. Economic development coupled with improving healthcare systems is expected to help the industry grow in this region.
  • Key companies of the wearable medical devices industry include Fitbit Inc., Garmin, Vital Connect, Omron Corp., Sotera Wireless, Jawbone, Pebble Technology Corp., Basis Science, Inc., Withings, Intelesens Ltd., Covidien Plc, LifeWatch AG, Polar Electro, Philips Electronics, and Everist Genomics

Read Our Blog: http://www.grandviewresearch.com/press-release/global-wearable-medical-device-market

Grand View Research has segmented the global Wearable Medical Device Market on the basis of products and region:

Global Wearable Medical Devices Product Outlook (USD million), 2012 – 2022

  • Diagnostic devices
    • Vital sign monitors
      • Heart rate monitors
      • Activity monitors
      • Electrocardiographs
      • Pulse oximeters
      • Spirometers
      • Blood pressure monitors
      • Other devices
    • Sleep monitoring devices
      • Sleep trackers
      • Wrist actigraphs
      • Polysomnographs
      • Other devices
    • Electrocardiographs Fetal & Obstetric Devices
    • Neuromonitoring devices
      • Electroencephalographs (EEG)
      • Electromyographs (EMG)
      • Other devices
    • Therapeutic devices
      • Pain management device
        • Neurostimulation device
        • Other devices
      • Insulin monitoring device
        • Insulin pumps
        • Other devices
      • Rehabilitation device
        • Accelerometers
        • Sensing devices
        • Ultrasound platforms
        • Others
      • Respiratory therapy device
        • Ventilators
        • PAP
        • Portable oxygen concentrators
        • Other devices

Global Wearable Medical Devices Application Outlook (USD million), 2012 – 2022

  • Sports & Faintness
  • Remote Patient Monitoring
  • Home healthcare

Global Wearable Medical Devices Site Outlook (USD million), 2012 – 2022

  • Handheld
  • Headband
  • Strap, clip, bracelet and watches
  • Shoe sensors
  • Others

Wearable Medical Devices Region Outlook (USD million), 2012 – 2020

  • North America
    • US.
    • Mexico
  • Europe
    • UK
    • Germany
    • France
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa
    • Saudi Arabia

Access Press Release  of this Report: http://www.grandviewresearch.com/press-release/global-wearable-medical-device-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Rising number of overweight and obese population coupled with growing popularity of various commercially available solutions is fueling the Market growth

The global weight management market is expected to reach USD 442.3 billion by 2025, according to a new report by Grand View Research, Inc. Rising number of overweight and obese population coupled with rising popularity of various commercially available solutions is fueling the growth.

global-weight-management-smarket.png

Increasing initiatives undertaken by market players in collaboration with the government to raise awareness about the adverse impact on health due to obesity are further anticipated to drive the market demand. The overweight and obese population are more prone to chronic diseases including diabetes, hypertension, and orthopedic diseases. Thus, rising awareness about weight management techniques is driving the market growth.

Thanks to westernization and urbanization, there is an increasing preference toward processed food as an alternative to home-cooked food. The increase in number of nuclear families coupled with a rise in the working population have fueled the demand for easily accessible & inexpensive fast food and takeaway meals. According to Statista, in 2015, revenue of fast food industry in the U.S was 203.2 billion. A hectic schedule coupled with increasing stress are resulting in higher intake of outside and takeaway food. This trend is anticipated to trigger the market growth.

Browse Full Research Report on Weight Management Market: http://www.grandviewresearch.com/industry-analysis/weight-management-market

Further Key Findings From the Study Suggest:

  • The growing prevalence of obesity primarily due to sedentary lifestyle and lesser physical activities is augmenting market growth
  • The rising awareness of available solutions for weight loss and management is driving the growth
  • In diet, the beverage segment holds the largest share owing to increasing consciousness amongst people about their eating habits and adoption of general & personalized diet plans for better metabolism and losing the extra weight. Whereas, rising popularity of supplements, shake mix, tablets, and capsules are projected to grow over the forecast period
  • Fitness equipment such as cardiovascular training, strength building, and other equipment used in maintaining the weight account for the largest share in weight management
  • Increasing R&D for developing minimally invasive and noninvasive equipment are anticipated to increase the usage of surgical equipment over the forecast period
  • The fitness center services segment held the largest share of market, however with digitalization, online weight loss services are anticipated to grow over the forecast period
  • In 2016, North America dominated the global market with the largest revenue share of over 46.0%, due to the rising overweight population and commercial availability of minimally invasive procedures and noninvasive equipment
  • Asia Pacific is expected to emerge as the fastest growing region during the forecast period, primarily due to growing awareness about the importance of losing & management of extra weight in order to avoid adverse health effects coupled with improving healthcare infrastructure and emerging medical tourism
  • Some of the major players are Herbalife International, Inc.; NutriSystem, Inc.; Weight Watchers International, Inc.; eDiets.com; BRUNSWICK CORPORATION; Ethicon US, LLC; and GOLD’S GYM

Read Our Blog: http://www.grandviewresearch.com/blog/weight-management-market-size-share

Grand View Research has segmented the weight management market by diet, equipment, services, and region:

Global Weight Management Diet Outlook (Revenue, USD Billion; 2014 – 2025)

  • Diet
    • Meals
    • Beverages
    • Supplements

Global Weight Management Equipment Outlook (Revenue, USD Billion; 2014 – 2025)

  • Fitness equipment
    • Cardiovascular training equipment
    • Strength Training equipment
    • Others
  • Surgical equipment
    • Minimally invasive/Bariatric equipment
    • Noninvasive surgical equipment

Global Weight Management Services Outlook (Revenue, USD Billion; 2014 – 2025)

  • Fitness centers
  • Sliming centers
  • Consultation services
  • Online weight loss services

Weight Management Regional Outlook (Revenue, USD Billion; 2014 – 2025)

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • South Africa

Access Press Release of this Report: http://www.grandviewresearch.com/blog/weight-management-market-size-share

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Fitness Equipment Market Is Expected To Surpass Easily Owing Initiatives From Government And Enterprises

The global Fitness Equipment Market is anticipated to reach USD 13.24 billion by 2022. Key factors that are expected to fuel growth include urbanization leading to changing lifestyles, growing awareness of health & wellness and drastic increase of obese population.

Emerging economies have been observing growing trend for healthcare programs across all segments. In addition, governments in these countries are persistently attempting to conceptualize and establish effective healthcare plans. The introduction of new fitness regimes and healthcare programs across various corporates to encourage employees is expected to trigger growth. Fitness equipment market is projected to grow at a CAGR of 3.6% from 2015 to 2022.

On the basis of equipment type, the industry is segmented into strength training, cardiovascular and devices such as trackers & monitors. Commonly used equipment across all age groups to maintain fitness and manage weight include stationary bicycles, treadmills, weightlifting machines and stair climbers.

Demand for cardiovascular training devices is comparatively greater than strength training devices on account of dual benefit of well-being and disease prevention. Cardiovascular training devices are estimated to strengthen their hold on the industry in the next seven years and grow at a CAGR exceeding 3.0% from 2015 to 2022 owing to its increased adoption. Cardiovascular training devices such as treadmills, stair machines, and rowing machines stair machines. They are extensively used to keep Body Mass Index (BMI) within limits and maintain body fitness.

To Request for Sample Copy of this report: http://www.grandviewresearch.com/industry-analysis/fitness-equipment-market

Health clubs and gyms accounted for nearly 45.0% of total market share and dominated the market in 2014 as they form an essential prerequisite for health clubs. However, home users buy different equipment for their use. Purchase of these devices by commercial firms such as hospitals, hotels, and corporate offices to enhance customer experience is also expected to drive growth in the market.

Asia Pacific is a lucrative market with a high requirement for advanced and sophisticated fitness equipment. It is projected to grow at a CAGR of over 7.0% from 2015 to 2022. Outsizing youth population coupled with increasing disposable incomes in emerging economies is anticipated to propel growth.

North America is expected to be a major market for this industry owing to rising overweight population. North America acquired nearly 45.0% of the total industry share in 2014 and is expected to continue the trend over the forecast period at a CAGR of over 2.0%.

Firms in this business are very competitive and strategize by introducing updated version of existing products or launching newer and improved equipment. Key strategies being adopted by the companies include product innovations and exclusivity owing to technological enhancements. Market players engage in forming alliances to gain market share and dominate the industry. It includes Cybex International Inc., Brunswick, Johnson Health Tech., Paramount, Precor and Nautilus Inc.

Read Our Blog: http://www.grandviewresearch.com/blogs/semiconductors-and-electronics

Grand View Research has segmented the global fitness equipment market on the basis of device, end-use, and region:

Fitness Equipment Device Outlook (Revenue, USD Million, 2012 – 2022)

  • Cardiovascular training
  • Strength training
  • Others

Fitness Equipment End-Use Outlook (Revenue, USD Million, 2012 – 2022)

  • Home
  • Health clubs
  • Others

Fitness Equipment Regional Outlook (Revenue, USD Million, 2012 – 2022)

  • North America
  • Europe
  • Asia Pacific
  • ROW

Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-fitness-equipment-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Rising Investment In Research And Development in the generation of improved diagnostic tools is primarily driving the growth for Transplant Diagnostic Market: Grand View Research, Inc.

The global transplant diagnostic market is expected to reach USD 895.2 million by 2024, according to a new report by Grand View Research Inc. The rising demand for organ transplantation is primarily fueling the demand for transplant diagnostics.

Constant healthcare research and development efforts are resulting in the introduction of technically advanced treatments, such as stem cell therapy and organ transplants. As a result, the adoption of these highly-advanced organ transplantation techniques is creating the demand for transplant diagnostics as they reduce the risk of infections and minimize the chances of an immune response through pre-operative assessments including histocompatibility tests, such as Human Leukocyte Antigen (HLA) typing, which determines donor-receiver organ or tissue compatibility prior to organ transplants.
transplant-diagnostic-market.png

In addition, pertinent organizations are supporting research and development initiatives in the field of organ transplant through grants and funding. As a result, innovative and advanced diagnostic tools are frequently entering into the market. On the other hand, high cost of the diagnostic tests is one of the major factors hindering the growth of the market.

Geographically, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa (MEA). North America and Europe together accounted for the largest market share in 2015. Developed economies and well-established healthcare infrastructure coupled with the presence of a highly developed research infrastructure are accelerating the adoption of organ and tissue transplant therapies in Europe and North America. As a consequence, the demand for transplant diagnostics is high in North America and Europe.

Wide adoption of HLA typing owing to its ability to determine organ compatibility between the donor and the receiver preceding organ transplants and to predict potential perioperative immunological complications is driving the growth of the molecular assay market in North America and Europe.

Asia Pacific is expected to show the fastest growth rate during the forecast period owing to the booming medical tourism in countries, such as India. Availability of advanced healthcare infrastructure and skilled professionals at alower costare anticipated to attract patients worldwide to this region for transplant procedures.

In addition, the presence of highly advanced healthcare infrastructure and the ongoing government initiatives to improve healthcare facilities in the country are collectively anticipated to boost the market growth in Japan during the forecast period. As a result, the Asia Pacific market is anticipated to reach USD 216.6 million in 2024.

Request for Sample copy of this report: http://www.grandviewresearch.com/industry-analysis/transplant-diagnostic-market

Further key findings from the study suggest:

  • The PCR-based molecular assay captured the largest share of the overall market in 2015. The large market share was mainly attributed to the extensive adoption of the PCR  technique in HLA typing.
  • The sequencing-based typing segment is anticipated to witness significant growth rate from 2016 to 2024. The escalation in the adoption of next generation sequencing (NGS) is the major factor expected to drive the growth of this segment during the forecast period.
  • The integration of sequencing with serological typing enhances diagnostic outcomes and, hence is expected to augment the growth of the sequencing segment during the forecast period
  • The reagents and consumables segment accounted for the largest market share in 2015. This large share is mainly attributed to the repeat purchase of these products.
  • North America captured the largest market share of around 38% in 2015 and is expected to maintain its dominance throughout the forecast period. Well-established research infrastructure, the increasing healthcare expenditure, high adoption rate ofthe advanced diagnostic techniques, and the growing R&D activities are some of the factors supporting the growth of the market in the region.
  • Asia Pacific is expected to witness significant growth during the forecast period owing to the expanding research opportunities, the increasing health care expenditure, and the rising awareness of organ donation in the region.
  • The booming medical tourism industry offers further growth opportunities for the market in Asia Pacific
  • Some major players in this market include Thermo Fisher Scientific, Inc., Illumina, Inc., F.Hoffmann La-Roche AG. Abbott Laboratories, Inc.,Qiagen N.V., Immucor Transplant Diagnostics, Inc., Bio-Rad Laboratories, Inc., Affymetrix, Inc.,  and Omixon Ltd.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/healthcare

Grand View Research has segmented the Transplant Diagnostic Market on the basis of technology, product, and geography.

Transplant Diagnostic Market by Technology, 2013 – 2024 (USD Million)

  • Molecular Assays
    • PCR-Based Molecular Assays
    • Sequencing-Based Molecular Assays
  • Non-Molecular Assays
    • Serological Assays
    • Mixed Lymphocyte Culture (MLC) Assays

Transplant Diagnostic Market by Product, 2013 – 2024 (USD Million)

  • Reagents and Consumables
  • Instruments
  • Software and Services

Transplant Diagnostics Market, by Region, 2013- 2024 (USD Million)

  • North America
    • S. Transplant Diagnostics Market by Product Type
    • Canada Transplant Diagnostics Market by Product Type
    • S.Transplant Diagnostics Market by Technology Type
    • Canada Transplant Diagnostics Market by Technology
  • Europe
    • Germany Transplant Diagnostics Market by Product Type
    • France Transplant Diagnostics Market by Product Type
    • Germany Transplant Diagnostics Market by Technology
    • France Transplant Diagnostics Market by Technology
  • Asia Pacific
    • China Transplant Diagnostics Market by Product Type
    • India Transplant Diagnostics Market by Product Type
    • China Transplant Diagnostics Market by Technology
    • India Transplant Diagnostics Market by Technology
  • Latin America
    • Brazil Transplant Diagnostics Market by Product Type
    • Mexico Transplant Diagnostics Market by Product Type
    • Brazil Transplant Diagnostics Market by Technology
    • Mexico Transplant Diagnostics Marketby Technology
  • MEA
    • South Africa Transplant Diagnostics Market by Product Type
    • South Africa Transplant Diagnostics Market by Technology

 About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com